Clin2
NCT07175454Possibly a fitNot yet recruiting

Anxiety and depression in people with Crohn's disease or ulcerative colitis

Inflammatory Bowel DiseasesMental Health Issue

Part of Digestive system clinical trials.

This study looks at how anxiety and depression affect people living with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. It aims to understand these connections to improve care and support for patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
450 people
Ages
16 years and older
Study type
Observational

Who can take part

  • You have a confirmed diagnosis of ulcerative colitis or Crohn's disease.
  • You currently receive infliximab or vedolizumab through an IV infusion (not a shot).
  • You are not still in the initial loading-dose phase of your infusion treatment.
  • You do not have any surgery planned in the next 12 months.
  • You are not planning to switch to a different advanced therapy or take a treatment break (drug holiday) in the next 12 months.
  • You do not have a stoma (an opening in your belly for waste).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04995224Recruiting
Study what causes long-term pain in new Crohn’s or colitis

This study looks at why some people develop long-term pain after being newly diagnosed with ulcerative colitis or Crohn’s disease. It may help researchers understand the pain process and improve future treatments.

London
NCT05733702Recruiting
Study of Crohn’s and ulcerative colitis treatment changes

This study follows adults with Crohn’s disease or ulcerative colitis when their treatment is changed. It collects health information and samples to better understand how treatment changes affect people over time.

Luxembourg
NCT06266663Recruiting
IBD study on social factors, medications, and quality of life

This study looks at how social and economic factors (like where you live and your access to care) affect medication use and quality of life for people with inflammatory bowel disease. By completing an online survey, you can help researchers understand these connections better.

New York, New York
NCT07431606Recruiting· Phase 2
Duloxetine for Inflammatory Bowel Disease

This study tests whether duloxetine, a medication used for pain and mood, can help people with inflammatory bowel disease (IBD) who are also dealing with high stress, disability, or gut-related anxiety.

Philadelphia, Pennsylvania
NCT07494227Not yet recruiting
Developing a self-care questionnaire for inflammatory bowel disease

This study is developing a new questionnaire to measure self-care in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis). By participating, you will help create a tool that may improve support for patients managing their condition at home.

Roma, RM
NCT04960826Recruiting
Study of an environmental risk factor in Crohn’s

This study looks at how an environmental factor may be linked to Crohn’s disease, especially around the time you need certain bowel surgery. Your experience may help researchers understand risk and how it relates to your gut health.

Lille

Hear when a new Mental Health Issue trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.